Clinical Trial Update: Gemcitabine vs Paclitaxel in Caribbean Women of African Ancestry With Metastatic Triple-Negative Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing gemcitabine to paclitaxel in metastatic triple-negative breast cancer among Caribbean women of African ancestry; currently not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: AntiCancer Research Jamaica | Conditions: Triple Negative Breast Cancer, Metastatic Triple-negative Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING